PMA device
Next Gen Patient System CM1200 CardioMEMS HERO Device
Abbott Medical · System, Hemodynamic, Implantable (MOM, Class III) · First FDA decision Feb 27, 2026, newest Feb 27, 2026Heart failure
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
305
Naming "Next Gen Patient"
MAUDE reports
0
Brand "Next Gen Patient", since 2015
PubMed studies
0
Mentioning "Next Gen Patient"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Next Gen Patient System CM1200 CardioMEMS HERO Device
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Next Gen Patient System CM1200 CardioMEMS HERO DevicePMA supplement
P100045-S086 · Decided Feb 27, 2026 · 182 days after receipt · Normal 180 Day Track
Device type: System, hemodynamic, implantable (MOM) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Next Gen Patient", any status and sponsor, newest update first.
- Effect of Prewarming Duration on Blood Flow After Colon Resection SurgeryPivotal-lookingRecruiting
Çiğdem Ünal KantekinGovernment (non-federal)
NCT07857538 · 108 participants (planned) · Start Oct 15, 2026 · Primary completion Feb 15, 2027
Device: Preoperative Forced-Air Warming · For: Perioperative Hypothermia
Sites: Kayseri, Turkey (Türkiye)
- AIRE-2 Device for Study of Breath Analysis in IBDActive, not recruiting
McMaster UniversityAcademic, hospital or other
NCT06541938 · 57 participants · Start Aug 28, 2024 · Primary completion Nov 2, 2026
Device: AIRE-2 Portable breath analyzer · For: Inflammatory Bowel Diseases
Sites: Hamilton, Canada
Hospital San Juan de Dios TenerifeAcademic, hospital or other
NCT07835334 · 30 participants (planned) · Start Jul 1, 2026 · Primary completion Sep 1, 2027
Device: Prophylactic Onlay Mesh Placement · For: Open Abdomen; Incisional Hernia; Definitive Fascial Closure and 2 more
Sites: Santa Cruz de Tenerife, Spain
302 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Next Gen Patient", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code MOM
12,295 reports: 7,687 malfunction, 4,377 injury, 226 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1427-2025 · Started Feb 3, 2025 · Posted by FDA Mar 21, 2025
Reason given: Due to issues associated with data migration of patient information and results to a Cloud service, the firm has received complaint associated with some patient profile information being duplicated while other patient information is missing.
Cause as FDA categorized it: Software design · Device type: System, Hemodynamic, Implantable (MOM)
Z-0987-2025 · Started Nov 6, 2024 · Posted by FDA Jan 17, 2025
Reason given: Due to a data migration from on-premises server to the cloud environment, some customers reported that they were not able to transmit readings.
Cause as FDA categorized it: Under Investigation by firm · Device type: System, Hemodynamic, Implantable (MOM)
Z-0988-2025 · Started Oct 5, 2024 · Posted by FDA Jan 17, 2025
Reason given: As a result of a cloud data migration of Patient and Hospital Electronic Systems (PES and HES) reverted to an outdated configuration causing incorrect/inaccurate pulmonary artery (PA) pressure readings.
Cause as FDA categorized it: Under Investigation by firm · Device type: System, Hemodynamic, Implantable (MOM)
10 more recall records with a free account
Published research
The most relevant PubMed records for "Next Gen Patient"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code MOM.
- CardioMEMS HF SystemAbbott Medical · PMA 2026
- Cordella Pulmonary Artery Sensor SystemEndotronix, Inc. · PMA 2026
- Cardiomems HF Pressure Measurement SystemAbbott Medical · PMA 2016
- CorPASS SystemEndotronix, Inc. · PMA 2025
- CardioMEMS patient and hospital electronicsAbbott Medical · PMA 2018
- CardiomemsAbbott Medical · PMA 2016
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.